Estimated antiretroviral therapy coverage among people living with HIV in Tajikistan
Tajikistan: Estimated antiretroviral therapy coverage among people living with HIV was 76.0% in 2025. ◆ Volatile
Estimated antiretroviral therapy coverage among people living with HIV in Tajikistan, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, estimated antiretroviral therapy coverage among people living with hiv in Tajikistan stood at 76.0%. That is the highest value across all 26 years on record.
The figure is up 5.6% on the previous year and up 216.7% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among people living with hiv in Tajikistan peaked at 76.0% in 2025 and was at its lowest, 0.0%, in 2000.
That places Tajikistan 66th out of 143 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Estimated antiretroviral therapy coverage among people living with HIV in Tajikistan, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 1.0% | — |
| 2008 | 1.0% | +0.0% |
| 2009 | 3.0% | +200.0% |
| 2010 | 5.0% | +66.7% |
| 2011 | 6.0% | +20.0% |
| 2012 | 8.0% | +33.3% |
| 2013 | 11.0% | +37.5% |
| 2014 | 16.0% | +45.5% |
| 2015 | 24.0% | +50.0% |
| 2016 | 31.0% | +29.2% |
| 2017 | 37.0% | +19.4% |
| 2018 | 44.0% | +18.9% |
| 2019 | 50.0% | +13.6% |
| 2020 | 55.0% | +10.0% |
| 2021 | 59.0% | +7.3% |
| 2022 | 63.0% | +6.8% |
| 2023 | 68.0% | +7.9% |
| 2024 | 72.0% | +5.9% |
| 2025 | 76.0% | +5.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.5% | 0.0% | 3.0% | 10 |
| 2010s | 23.2% | 5.0% | 50.0% | 10 |
| 2020s | 65.5% | 55.0% | 76.0% | 6 |
Countries ranked near Tajikistan
- 64 Senegal 77.0% compare
- 64 Antigua and Barbuda 77.0% compare
- 66 Morocco 76.0% compare
- 66 Central African Republic 76.0% compare
- 66 Canada 76.0% compare
More health data for Tajikistan
- Un projection of annual infant deaths, annual growth rate -1.94 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.9561 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 887 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,061 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2021)
- Population ages 00-04, female, annual growth rate -0.6758 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0596 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.6416 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among people living with hiv in Tajikistan?
- Estimated antiretroviral therapy coverage among people living with hiv in Tajikistan was 76.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among people living with hiv recorded in Tajikistan?
- The highest recorded value was 76.0% in 2025.
- What is the lowest estimated antiretroviral therapy coverage among people living with hiv recorded in Tajikistan?
- The lowest recorded value was 0.0% in 2000.
- How does Tajikistan rank for estimated antiretroviral therapy coverage among people living with hiv?
- Tajikistan ranks 66th out of 143 countries with data for 2025.
- Is estimated antiretroviral therapy coverage among people living with hiv rising or falling in Tajikistan?
- Over the last ten years it is up 216.7%. The long-run trend across the full record is volatile.
- Where does this Tajikistan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).